Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival
2 Visualizações
• 07/10/23
0
0
Embutir
administrator
Assinantes
The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).
Mostre mais
Comentários do Facebook
SORT BY-
Melhores Comentários
-
Últimos Comentários